MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcomaMarielle E. Yohe, Javed Khan, Hsien-Chao Chou et al.|Science Translational Medicine|2018Cited by 155
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcomaTimothy McKinnon, Rebecca A. Gladdy, Rosemarie E. Venier et al.|Oncogene|2018Cited by 51